Furthering our unpacking of the mentaltech space, let’s take a look at the subcategory of therapeutic mobile apps. These have an overlap with telepsych and VR categories, consists largely of eXBT apps. [eXBT = electronic miscellaneous behavioral therapies] I define these apps as those that either: 1) deliver therapy, or 2) are approved therapeutic agents themselves. Anecdotally, I think the greatest volume of mentaltech applications, across all categories, are here.

Therapy Deliverers

Therapeutic apps are a blessing in their allowance of a greater reach, frequency and convenience of therapy access, delivered in: a) synchronous human, b) asynchronous human and c) artificial intelligence contexts. Therapy delivering apps, as distinct from “therapy themselves” apps can come in the form of: a) wellness care delivery like “predictive AI assisted” Mindoula or YouPer, and “personal routes oriented” MindDistrict, or b) psycho-education and brain training like Happy Neuron. This is a crowded space where differentiations can be thin and difficult to nail down.

From a business model standpoint, “therapy delivery” apps makes for relatively lower development costs, and faster funding and revenue generation on the basis of use of already proven therapeutic methods. The hazard to this approach is “low barriers to entry” as can be seen by how crowded this subspace is. Let’s keep observing how this subspace shakes out, and who is left standing. One might also say there is no need for shakeout when you consider the magnitude of unmet demand for such services that still exists all over the planet.

Upon discovering this category, it left me with the impression that “an” alternate description of space might be “monetized and democratized XBT”. 🙂 Behavioral therapies are far from new. Their merger with electronic means give them tremendous additional scale potential all over the world. That said, there is a lot of work ahead to convert investment and development into adoption with usability, security, belief in efficacy, and affordability still forming adoption barriers.

Therapies Themselves

Therapeutic applications which are themselves therapies are typified by a regulatory review and approval that essential classify them as a diagnostic/medical device or agent, companion to, or part of, a pharmacologic, or biologic. When we hear the newly popularized term, digital therapeutics like with Proteus Digital Health or Pear Therapeutics, this is the type of company being referred to. For those deeply interested in this area, check out the recently minted Digital Therapeutics Alliance.

From a business model stand point, “therapies themselves”, take more investment, and patience, to conduct the research studies and reviews to obtain regulatory approval. This credential established, they have higher barriers to competitive entry and the basis for asking for greater revenues per transaction.

Again, the beauty of this category is in how it is expanding:

The usual cautionary suspects are:

Thanks again for reading and spreading word on The Digital Mental Health Project and take a few minutes to respond to our Digital Stress Management Survey. Please also subscribe to get the latest notices regarding our work in your inbox

Be well.

Leave a Reply

Your email address will not be published. Required fields are marked *